Targeting RNA with Therapeutics - Dr. Matthew Disney

from Talking Biotech with Dr. Kevin Folta

SummaryIn this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics.

Episode metadata supplied by the publisher feed · Published Oct 5, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Targeting RNA with Therapeutics - Dr. Matthew Disney

0:00 41:36

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talking Biotech with Dr. Kevin Folta?

This episode is 41 minutes long.

When was this Talking Biotech with Dr. Kevin Folta episode published?

This episode was published on October 5, 2025.

Can I download this Talking Biotech with Dr. Kevin Folta episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!